Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Trientine (A16Ax12) As Part Of A So-Called Open-House Model.